Mobile menu open

Cambridge Cancer Research Hospital Update

In a statement to the House of Commons today (25 May), the Secretary of State for Health and Social Care announced that plans for Cambridge Cancer Research Hospital on the Cambridge Biomedical Campus, can proceed and will be funded.

A woman in a face mask holding test tubes
Architect image of Cambridge Cancer Research Hospital and neighbours AstraZeneca (bottom left), Royal Papworth Hospital (bottom right) and Addenbrooke's Hospital.

We await final sign off of our Outline Business Case. This sets out the vision, benefits and value for money that Cambridge Cancer Research Hospital will offer, following review by the NHSE and HM Treasury Joint Investment Committee in March.

In naming the new specialist cancer research hospital as one of the Cohort 2 schemes, the Secretary of State confirmed that the plans would be funded as part of the New Hospital Programme.

Additional fundraising and philanthropy will also be required, as has always been the case.

Watch how our hospital will make a difference to patients


Cambridge Cancer Research Hospital, a partnership between Cambridge University Hospitals and the University of Cambridge, will combine NHS clinical space with three new research institutes that will support the ambitions set out in the government's Life Science Strategy and the NHS Long Term Plan.

Bringing together world-class NHS clinicians with cutting-edge University and industry-led research, the hospital will accelerate the early detection of cancer and lead the way in delivering bespoke, precision treatments that will radically improve patient outcomes.

Construction of the new seven storey, 26,000 m2 building is set to begin in 2024. A full planning application was submitted to Cambridge City Council in January 2023 and we expect to receive a decision this summer.